Pay in 4 interest-free payments of $5.99 Learn more
Ships within 48 hours · Estimated delivery Aug 29 - Sep 3
Wang Y, Hunt K, Nazareth I, Freemantle N, Petersen I
Clinical Trial Outcomes by Compound Semaglutide has the most extensive clinical dataset, including the STEP program (weight management), SUSTAIN program (type 2 diabetes), PIONEER program (oral semaglutide), and SELECT (cardiovascular outcomes)
These participants also experienced significant improvements in total fat masslosing 17 kg and 15 kg, respectivelyabdominal fat, which reduced by 48% and 41%, and liver fat, reducing by 39% and 34%, compared to the placebo
however, in March, 23andMe filed for Chapter 11 bankruptcy protection amid financial struggles, including a significant data breach in 2023 and declining revenues
US$ 22.56
US$ 20.34
US$ 20.13
US$ 25.30
US$ 29.57
